Vident Investment Advisory’s Accendra Health ACH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-56,752
Closed -$1.78M 1259
2022
Q2
$1.78M Buy
56,752
+4,184
+8% +$152K 0.05% 437
2022
Q1
$2.31M Buy
52,568
+6,824
+15% +$293K 0.06% 393
2021
Q4
$1.99M Buy
45,744
+1,840
+4% +$72.1K 0.05% 457
2021
Q3
$1.37M Sell
43,904
-23,764
-35% -$935K 0.04% 578
2021
Q2
$2.86M Sell
67,668
-789
-1% -$30.7K 0.09% 262
2021
Q1
$2.57M Buy
+68,457
New +$2.14M 0.09% 263
2019
Q1
Sell
-73,405
Closed -$465K 787
2018
Q4
$465K Sell
73,405
-2,818
-4% -$29.3K 0.03% 602
2018
Q3
$1.26M Sell
76,223
-60,650
-44% -$1.03M 0.05% 416
2018
Q2
$2.29M Buy
136,873
+14,214
+12% +$230K 0.09% 301
2018
Q1
$1.95M Buy
122,659
+19,095
+18% +$340K 0.08% 313
2017
Q4
$1.96M Buy
103,564
+16,912
+20% +$375K 0.09% 287
2017
Q3
$2.53M Buy
86,652
+3,328
+4% +$98.3K 0.14% 224
2017
Q2
$2.68M Buy
83,324
+5,970
+8% +$196K 0.22% 126
2017
Q1
$2.68M Buy
77,354
+12,813
+20% +$458K 0.27% 109
2016
Q4
$2.28M Buy
64,541
+664
+1% +$22.4K 0.28% 180
2016
Q3
$2.22M Buy
63,877
+3,880
+6% +$136K 0.29% 164
2016
Q2
$2.24M Sell
59,997
-57,969
-49% -$2.18M 0.32% 144
2016
Q1
$4.77K Buy
117,966
+60,315
+105% +$2.25M 0.29% 113
2015
Q4
$2.07M Buy
57,651
+33,569
+139% +$1.21M 0.26% 207
2015
Q3
$769K Buy
24,082
+6,309
+35% +$215K 0.11% 287
2015
Q2
$604K Buy
17,773
+655
+4% +$22.1K 0.08% 377
2015
Q1
$579K Buy
17,118
+4,015
+31% +$140K 0.12% 305
2014
Q4
$460K Buy
+13,103
New +$441K 0.16% 279

Other funds holding ACH

Vident Investment Advisory's ACH Position: Q3 2022 in Review

Vident Investment Advisory sold out of Accendra Health (ACH) in Q3 2022, closing a stake of 56,752 shares — an estimated $1.78M sold.

Vident Investment Advisory first reported a position in ACH in Q4 2014 and held it in 23 quarters. The position peaked at $2.86M in Q2 2021. 227 funds tracked by Wall St. Rank hold ACH as of Q3 2022.

  • Vident Investment Advisory reported no remaining Accendra Health position as of Q3 2022 after selling out during the quarter.
  • Vident Investment Advisory sold 56,752 Accendra Health shares in Q3 2022, an estimated $1.78M.
  • Vident Investment Advisory first reported a position in Accendra Health in Q4 2014 and held it in 23 quarters.
  • Vident Investment Advisory's Accendra Health position peaked at $2.86M in Q2 2021.
  • 227 funds tracked by Wall St. Rank held Accendra Health as of Q3 2022.

Based on Vident Investment Advisory's 13F filing for Q3 2022, filed 14 Nov 2022.